| Earnings Per Share |
Earnings Per Share The following table summarizes earnings per share calculations: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Basic earnings per common share | | | | | | | | | Net income (loss) attributable to Quaker Chemical Corporation | $ | 29,977 | | | $ | 30,469 | | | $ | 76,481 | | | $ | (23,189) | | | Less: income (loss) allocated to participating securities | 11 | | | 30 | | | 31 | | | (44) | | | Net income (loss) available to common shareholders | $ | 29,966 | | | $ | 30,439 | | | $ | 76,450 | | | $ | (23,145) | | | Basic weighted average common shares outstanding | 17,196,928 | | 17,363,947 | | 17,273,816 | | 17,524,377 | | Basic earnings (loss) per common share | $ | 1.74 | | | $ | 1.75 | | | $ | 4.43 | | | $ | (1.32) | | | | | | | | | | | Diluted earnings per common share | | | | | | | | | Net income (loss) attributable to Quaker Chemical Corporation | $ | 29,977 | | | $ | 30,469 | | | $ | 76,481 | | | $ | (23,189) | | | Less: income (loss) allocated to participating securities | 11 | | | 30 | | | 31 | | | (44) | | | Net income (loss) available to common shareholders | $ | 29,966 | | | $ | 30,439 | | | $ | 76,450 | | | $ | (23,145) | | | Basic weighted average common shares outstanding | 17,196,928 | | 17,363,947 | | 17,273,816 | | 17,524,377 | | Effect of dilutive securities | 148,401 | | 57,143 | | 89,700 | | 21,289 | | Diluted weighted average common shares outstanding | 17,345,329 | | 17,421,090 | | 17,363,516 | | 17,545,666 | | Diluted earnings (loss) per common share | $ | 1.73 | | | $ | 1.75 | | | $ | 4.40 | | | $ | (1.32) | |
Certain stock options, restricted stock units, and PSUs are not included in the diluted earnings per share calculation when the effect would be anti-dilutive. The number of anti-dilutive shares were 13,907 and 23,262, respectively, for the three and nine months ended September 30, 2026, compared to 27,037 and 41,854, respectively, for the three and nine months ended September 30, 2025
|